AngioDynamics to Present at the UBS Global Healthcare Conference

About this update from Angiodynamics, Inc.

[{"type":"text","content":" LATHAM, N.Y.--(BUSINESS WIRE)--\nAngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the UBS Global Healthcare Conference at 4:15 p.m. ET on Monday, May 23, 2022.\n\nA live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.\n\nAbout AngioDynamics, Inc.\n\nAngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients.\n\nThe Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20220516005937/en/\n\nInvestor Contact:\nAngioDynamics, Inc.\nStephen Trowbridge, Executive Vice President & CFO\n(518) 795-1408\n\nSource: AngioDynamics, Inc.","length":3016,"tagName":"div"}]

More updates from Angiodynamics, Inc.